Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis
- PMID: 24374889
- DOI: 10.1093/ije/dyt243
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis
Abstract
Background: Needle and syringe programmes (NSP) aim to reduce the risk of HIV by providing people who inject drugs (PWID) with sterile injecting equipment. A recent review of reviews (ROR) concluded that there was only tentative evidence to support the effectiveness of NSP in reducing HIV. We carried out a systematic review and meta-analysis to assess the association between NSP and HIV transmission.
Methods: Relevant primary articles presenting data on the risk of HIV transmission associated with NSP were identified in two stages: (i) from reviews identified in two published RORs (covering the period 1980-2008); and (ii) a literature search of CINAHL, Cochrane Library, EMBASE, MEDLINE and PsychINFO for primary articles published since the most recent high quality review (covering the period 2008-12). Study results were synthesized using random-effects meta-analysis.
Results: There were 12 studies comprising at least 12 000 person-years of follow-up. Exposure to NSP was associated with a reduction in HIV transmission: pooled effect size 0·66 [95% confidence interval (CI) 0·43, 1·01] across all studies, and 0·42 (95% CI 0·22, 0·81) across six higher quality studies (according to the Newcastle-Ottawa tool).
Conclusions: There is evidence to support the effectiveness of NSP in reducing the transmission of HIV among PWID, although it is likely that other harm reduction interventions have also contributed to the observed reduction in HIV risk. NSP should be considered as just one component of a programme of interventions to reduce both injecting risk and other types of HIV risk behaviour.
Keywords: HIV; needle-exchange programmes; people who inject drugs.
Similar articles
-
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2. Cochrane Database Syst Rev. 2017. PMID: 28922449 Free PMC article. Review.
-
Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.Addiction. 2010 May;105(5):844-59. doi: 10.1111/j.1360-0443.2009.02888.x. Epub 2010 Mar 2. Addiction. 2010. PMID: 20219055 Review.
-
Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.Int J Drug Policy. 2014 Jan;25(1):34-52. doi: 10.1016/j.drugpo.2013.07.001. Epub 2013 Aug 21. Int J Drug Policy. 2014. PMID: 23973009 Review.
-
Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews.BMC Public Health. 2017 Apr 11;17(1):309. doi: 10.1186/s12889-017-4210-2. BMC Public Health. 2017. PMID: 28399843 Free PMC article. Review.
-
Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020).Int J Drug Policy. 2022 Nov;109:103872. doi: 10.1016/j.drugpo.2022.103872. Epub 2022 Oct 3. Int J Drug Policy. 2022. PMID: 36202039 Review.
Cited by
-
Rapid Assessment Amid an Injection Drug Use-Driven HIV Outbreak in Massachusetts' Merrimack Valley: Highlights from a Case Study.AIDS Behav. 2024 Nov 8. doi: 10.1007/s10461-024-04540-7. Online ahead of print. AIDS Behav. 2024. PMID: 39511061
-
A hand-washing community-based educational intervention to reduce abscess incidence among people who inject drugs: a cluster randomised controlled clinical trial protocol (the HAWA study protocol).BMC Public Health. 2024 Oct 17;24(1):2858. doi: 10.1186/s12889-024-20299-x. BMC Public Health. 2024. PMID: 39420312 Free PMC article. Clinical Trial.
-
From Response to Prevention: Enhancing EMS Impact With Harm Reduction and HIV Education.Cureus. 2024 Sep 7;16(9):e68884. doi: 10.7759/cureus.68884. eCollection 2024 Sep. Cureus. 2024. PMID: 39376841 Free PMC article.
-
Examining the evolving landscape of liver cancer burden in the United States from 1990 to 2019.BMC Cancer. 2024 Sep 4;24(1):1098. doi: 10.1186/s12885-024-12869-4. BMC Cancer. 2024. PMID: 39232707 Free PMC article.
-
A qualitative exploration of harm reduction in practice by street-based peer outreach workers.Harm Reduct J. 2024 Aug 30;21(1):161. doi: 10.1186/s12954-024-01076-w. Harm Reduct J. 2024. PMID: 39210459 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

